RKDA

Arcadia Biosciences Inc.

Price

$0.45

return (12m)

-87.46%

p/e

-0.12

p/bv

2.10

DIVIDEND YIELD

0.00%

RKDA price

Arcadia Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RKDA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-3.38%

3 months

-41.19%

1 year

-87.46%

2 years

-84.51%

5 years

-99.45%

10 years

-99.97%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals RKDA

Valuation

P/E

-0.12

Sector 12.95

Industry 23.38

P/BV

2.10

Sector 1.96

Industry 2.83

P/Revenue (PSR)

0.28

Sector 1.40

Industry 1.57

EV/EBITDA

5.75

Sector 20.44

Industry 37.27

EV/EBIT

5.75

Sector 27.00

Industry 62.16

P/EBITDA

-0.33

Sector 5.88

Industry 15.62

P/EBIT

-0.33

Sector 5.95

Industry 11.55

P/Total Assets

0.23

Sector 1.01

Industry 1.05

P/Net Current Assets

2.77

Sector -4.64

Industry -1.47

P/Working Capital

0.32

Sector 4.47

Industry 13.37

EPS

-3.72

Sector 1.71

Industry 5.25

BVPS

0.21

Sector 24.18

Industry 31.35

Efficiency

Gross Margin

34.60%

Sector 28.21%

Industry 23.75%

EBITDA Margin

-34.37%

Sector 15.00%

Industry 17.01%

EBIT Margin

-34.37%

Sector 10.30%

Industry 11.78%

Operating Margin

-80.15%

Sector 8.53%

Industry 11.19%

Net Profit Margins

-100.00%

Sector 4.62%

Industry 7.47%

Asset Turnover

0.24

Sector 0.17

Industry 0.20

Profitability

ROE

-1,758.45%

Sector 6.44%

Industry 21.61%

ROA

-188.89%

Sector 2.66%

Industry 6.13%

ROIC

-432.24%

Sector -21.63%

Industry 6.97%

Dividends

Dividend yield

0.00%

Sector 0.70%

Industry 2.52%

Payout

Sector 16.64%

Industry 75.20%

Debt

Current Ratio

3.49

Sector 1.89

Industry 1.73

Net Debt / EBITDA

8.42

Sector 0.96

Industry 3.91

Net Debt / EBIT

8.42

Sector 0.76

Industry 8.83

Net Debt / Equity

-6.60

Sector 0.09

Industry 0.84

Gross Debt / Equity

0.00

Sector 0.25

Industry 0.93

Equity/Assets

0.11

Sector 0.52

Industry 0.38

Liabilities/Assets

0.89

Sector 0.47

Industry 0.70

Growth

5Y Revenue CAGR

-6.89%

Sector -

Industry -

5Y Earnings CAGR

-7.16%

Sector -

Industry -

Fundamentals RKDA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
RKDA Arcadia Biosciences Inc.	$0.45	-87.46%	0.00%	-0.12	2.10	-1,758.45%	-100.00%
LIN Linde PLC	$460.40	-2.58%	1.37%	29.30	5.22	17.83%	20.43%
SHW The Sherwin-Williams Co.	$320.73	-6.64%	1.00%	28.95	20.19	69.74%	11.01%
APD Air Products and Chemicals Inc.	$284.18	1.19%	2.50%	29.98	4.09	13.64%	17.13%
ALB Albemarle Corporation	$110.91	37.88%	1.20%	56.99	1.51	2.64%	4.71%
BCPC Balchem Corporation	$167.05	7.39%	0.58%	32.01	4.04	12.62%	15.14%
CTVA Corteva Inc.	$80.53	14.70%	0.89%	34.28	2.12	6.18%	11.29%
CF CF Industries Holdings Inc.	$127.70	53.14%	1.62%	7.96	2.23	28.03%	32.30%
PPG PPG Industries Inc.	$104.52	-1.98%	2.75%	14.74	2.70	18.35%	9.60%
DD DuPont de Nemours Inc.	$129.01	33.91%	1.87%	207.67	1.26	0.61%	1.20%
NDSN Nordson Corporation	$311.57	40.66%	1.06%	30.99	5.26	16.98%	18.63%
EMN Eastman Chemical Company	$65.69	7.30%	5.20%	16.62	1.19	7.17%	5.00%
HWKN Hawkins Inc.	$122.20	-29.28%	0.63%	31.52	4.64	14.71%	7.29%
IFF International Flavors & Fragrances Inc.	$82.96	34.37%	1.92%	79.40	1.51	1.91%	3.61%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RKDA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Arcadia Biosciences

Arcadia Biosciences Inc.

Average Investor10 user rating

4.0 (2 people)

United States

11 years

Founded: 2015

2015

Time since IPO - 11 years

58

Employees

Arcadia Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.33 million, with shareholders equity totaling $633.00 Thousand.

The company employs approximately 58 people and operates in the Basic Materials sector, within the Chemicals Manufacturing industry.

Over the past 12 months, Arcadia Biosciences Inc. reported $4.75 million in revenue, generating net income of $-11.13 million.

Key financial metrics include a P/E ratio of -0.12, a price-to-book (P/B) ratio of 2.10, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RKDA.

Market cap

$1.33 million

Net worth

$633.00 Thousand

$633,000.00

Assets

$5.89 million

$5,893,000.00

Total Shares Outstanding

2.99 million

2,992,000

Average Daily Trading Volume

$129.14 Thousand

$129,140.34

Sector

Basic Materials

Industry

Chemicals Manufacturing

RKDA

RKDA revenue and profits

Financial Results RKDA

DRAG THE FRAME TO SEE MORE DATA

RKDA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

MT - ArcelorMittal

$72.50 108,42% (12M)

P/E

22.91

0.97%

ROE

4.22%

P/BV

0.97

RIO - Rio Tinto

$97.36 67,69% (12M)

P/E

6.88

4.23%

ROE

31.21%

P/BV

2.15

BHP - BHP Group

$86.27 76,09% (12M)

P/E

11.28

3.16%

ROE

33.47%

P/BV

3.78

BBL - BHP Group

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

34.25%

P/BV

0.00

DOW - Dow

$28.73 26,74% (12M)

P/E

-20.77

4.90%

ROE

-5.74%

P/BV

1.19

PKX - POSCO

$58.21 17,55% (12M)

P/E

29.26

2.17%

ROE

1.41%

P/BV

0.41

NTR - Nutrien Ltd

$77.09 40,80% (12M)

P/E

15.61

2.83%

ROE

9.18%

P/BV

1.43

VALE - Vale SA ADR

$14.21 41,88% (12M)

P/E

28.62

7.56%

ROE

5.42%

P/BV

1.55